LATEST NEWS
- All news
-
43Awards
-
9Burden of Osteoporosis
-
74Capture the Fracture
-
1Exercise
-
1FRAX
-
84IOF
-
34IOF Positions and Statements
-
1IOF Tour Latin America
-
20Meetings
-
66Member News
-
9Nutrition
-
36Policy
-
6Prevention
-
50Research
-
28Scientific Journals
-
13Skeletal Rare Diseases
-
7Training Courses
-
15Treatment
-
30World Osteoporosis Day
- News room - Latin America Region
Osteoporosis in the spotlight at the 6th International Medical Congress of Armenia
The Armenian Osteoporosis Association, an IOF member society, has reported on the successful satellite symposium entitled "Bone Loss Due to Cancer and Other Etiologies", which took place within the framework of the 6th International Medical Congress of Armenia (IMCA), on July 4, 2023. It was held at the Manoogian Hall of the American University of Armenia supported by the American University of Armenia and organized by Prof. John Bilezikian, with lectures given by leading specialists from Armenia and the USA․
Highlights of the Symposium were briefly discussed in this article, as shown below.
John Bilezikian MD, Professor of Columbia University Medical Center, New York, NY, Vice Chair of the Dept. of Medicine for International Education and Research, Chief Emeritus, of the Division of Endocrinology, Director of the Metabolic Diseases Division, and board member of the international guidelines development organization, stated: “The topic of cancer that we have targeted today is very relevant, because many people suffering from cancer have bone loss, and this issue is not much touched and discussed, but in fact it poses a serious danger. During this event we succeeded to present some statistical data on myeloma, which is very informative for the specialists. We have targeted not only cancer but also diabetes, thyroid body. The point is that in case of the above-mentioned diseases use of certain drugs can adversely affect the bone system. So, it is crucial to ignore bone density screenings.
I have visited Armenia every year since 2007 to organize different conferences, and they were regular visits before Covid-19. Our goal is not only to raise the scientific level of medical workers in Armenia, but to make Armenia a center of knowledge for the whole Europe and Eurasia.”
Dr. Varta Babalyan, President of Osteoporosis Armenian Association, Executive Director of Osteoporosis Center, stated: “Professor Bilezikian has made a great contribution to the field of osteoporosis in Armenia. In 2007, when he visited Armenia for the first time within the framework of an international symposium, there was only 1 densitometer in Armenia. He brought another densitometer with him. At the moment, 15 densitometers are in operation in Armenia, including Artsakh and regions, 11 of which were donated by Prof. Bilezikian. In 2016, he founded the Osteoporosis Center, which has the purpose of increasing the knowledge of osteoporosis among doctors and society. Continuous courses are held in the center, and guidelines of leading international universities and organizations are presented."
"The results of the densitometric studies carried out in the center are given in accordance with the ISCD guidelines, and specialists (endocrinologists, rheumatologists, family doctors) provide consultations, and relevant literature is provided. Within the scope of the center's activities, research is also carried out, the results of which contribute to the implementation of new programs. All doctors of the center are trained in the field of osteoporosis through international conferences and training."
“The reason for Prof. Bilezikian's two-year delay in arriving in Armenia was the COVID-19 pandemic, but he participated in scientific conferences held in Armenia online during that time. With his activities, he is trying to make Armenia known to the whole world: he organized 3 international summits, where international leading specialists in the field of osteoporosis were invited. When participating at various medical conferences, he wears a tie and wristwatch in the colors of the tricolor flag of Armenia, thus reminding of Armenia.”
Dr. Marian Manoukian, PhD, Stanford, Endocrinology and Metabolism, California, USA, talked about diabetes and bone fractures:
“I tried to find out where their connection is and where their paths, so called, cross. Both diabetes and osteoporosis are very common diseases. Disease prevention is most important, because advanced disease is difficult to treat. Although prevention is not easy, you cannot prevent it in an instant. Preventive measures should start from a young age: children must do sports, different physical exercises, lead a healthy lifestyle, eat properly. By the way, in the Soviet period team sports have been popular, and it was right. Unfortunately, I don't see children doing sports in Armenia today. It is clear: gym visits are not affordable, and insurance companies do not cover them.who spoke about diabetes and bone fractures, and also said that disease prevention is important, because advanced disease is difficult to treat. She added: “Unfortunately, I don't see children doing sports in Armenia today. It is clear: gym visits are not affordable, and insurance companies do not cover them.”
Dr. Armine Haroyan, Head of Rheumatology Department, Erebuni Medical Center, Armenia, stated: “As a rheumatologist, I emphasized glucocorticosteroids in my talk, referring to those patients who have rheumatoid arthritis, of which many use steroids. In other words, different hormonal drugs, which in turn favour osteoporosis disease. The most important thing here is that our doctors, especially the young ones, are unaware of how early preventive measures should be started to avoid complications such as osteoporosis as a consequence of the treatment of the above-mentioned diseases. It is very important to treat osteoporosis in time.We have been constantly talking about it since 2015, because not only rheumatologists should be aware of the problem, but also related specialists who also use hormones, including pulmonologists, endocrinologists."
"Such events allow to present scientific and medical data, to deliver the information to the general medical society.”
Dr. Varduhi Petrosyan, PhD, Dean, AUA Turpanjian College of Health Sciences, Armenia, stated: “I would like to express our gratitude to Dr. Belizikian, who started this series of conferences more than 10 years ago, informing our doctors about the importance of osteoporosis prevention. Today's event showed that all parts of our health are interconnected. The event was dedicated to how bone health is affected when people have diabetes or cancer diseases. The course of treatment of these diseases can affect the bones, which, however, are not paid attention to not only in Armenia, but throughout the world. They do not study the condition of bones in a cancer patient: whether preventive measures should be applied or not, so that the quality of life does not suffer. I value it a lot when different specialists get together to try to find out how to cooperate in order to maintain human health.”
Dr. Nicholas Hutchings, Internal Medicine-Primary care, UCLA, Los Angeles, USA, also spoke at the Symposium. “My talk was about thyroid disease and its effect on bones. It is a very important topic. In women over 65, we have to screen the thyroid gland and check for osteoporosis disease presence, both of which are common diseases. It seems that they are two independent and separate processes, but in fact, their paths cross. Thyroid disease itself can cause osteoporosis."
"Generally, women are advised to undergo thyroid screening every year and a bone density test every two years. If a thyroid problem is detected, bone density must be checked without further delay. Why only in women? - because after menopause changes in their endocrine profile occur, as a result of which both the thyroid body and bones are affected."
On Day Two, July 5, the meeting of endocrinologists with Prof. John Bilezikian, took place in a very warm and friendly atmosphere. The doctors had the opportunity to communicate directly with the leading expert on parathyroid diseases, Prof. John Bilezikian, and this was a unique chance to ask all questions (they are more than a few in the case of parathyroid) to the author of the guidelines. He kindly answered all the questions, and the discussions around the presented medical cases became another way of analyzing the guidelines.